Parenteral Drug (India) share price
BSE: 524689Pharmaceuticals & Biotechnology
Trading suspended since 3 Feb 2025
Last traded ₹2.90 on 21 Aug 2023
Latest announcements
Routine notices left out.Share news and announcements
Feb 2025
3 Feb · Suspension of Trading
Trading in the equity shares of Parenteral Drugs (India) Limited (PDPL) shall remain suspended pursuant to intimation received from the Company. As per Resolution Plan the existing equity shares of the Company shall stand delisted with Nil payment. For the detailed corporate announcement submitted by the Company please refer the Exchange website.
Jan 2025
23 Jan · Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
Results
Standalone, as consolidated accounts are on record for only 6 of the last ten years; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the year to Mar 2016.Quarterly results
Quarter to Mar 2022, against the quarter beforeFiled 16 Jun
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.77 Crup 22.94%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- ₹24 CrQuarter to Dec 2021: −₹35 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 1,343.0%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 9 of the 9 years with results on record
The years either side of a change of basis do not compare. From the year to Mar 2018, the company's revenue for that year, ₹33 Cr, differs from its quarters added, ₹36 Cr.
| ₹ crore | Jun 2020Filed 25 Aug | Sep 2020Filed 14 Nov | Dec 2020Filed 15 Feb | Mar 2021Filed 8 Jul | Jun 2021Filed 11 Aug | Sep 2021Filed 17 Nov | Dec 2021Filed 17 Feb | Mar 2022Filed 16 Jun |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9 | 4.6 | 2.0 | 2.6 | 2.9 | 2.4 | 1.4 | 1.8 |
| Net profit | −32.2 | −33.7 | −31.0 | −24.8 | −32.0 | −33.6 | −34.5 | 23.8 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −1,103.8% | −725.5% | −1,520.4% | −966.7% | −1,093.2% | −1,430.2% | −2,393.7% | 1,343.0% |
Standalone. The last eight quarters. The latest is shaded.
Business segments
In the year to Mar 2022 the company reports one business segment, Pharmaceuticals, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2022, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +14.3% | – | – | 0.0% |
| 3 years | −24.8% | – | – | 0.0% |
| 5 years | −33.2% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 13 Sep 2010 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 23 Dec 2009 | Dividend | ₹1.50 |
| 24 Sep 2008 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.50 |
| 21 Sep 2007 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.50 |
Latest payments, as declared, by ex-date.
Parenteral Drug (India) share price by year
Each calendar year to 2023.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2023BSE close | 2.90 | −28.4% | 5.04 | 2.85 |
| 2022BSE close | 4.05 | +6.6% | 5.60 | 2.90 |
| 2021BSE close | 3.80 | +46.2% | 4.65 | 2.55 |
| 2020BSE close | 2.60 | −28.8% | 3.75 | 2.40 |
| 2019BSE close | 3.65 | −56.8% | 14.90 | 2.30 |
| 2018 | 8.45 | −66.9% | 25.65 | 7.50 |
| 2017 | 25.55 | +15.1% | 30.35 | 16.65 |
| 2016 | 22.20 | −52.8% | 77.40 | 19.90 |
| 2015 | 47.05 | +97.3% | 52.25 | 16.80 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2021 is from its first session, 1 Mar 2021. The close is the year's last trade for 2023 (21 Aug 2023) and 2020 (9 Mar 2020).
Recent sessions
The last 10 trading days to 21 Aug 2023, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 21 Aug 2023 | 2.70 | 2.90 | 2.70 | 2.90 | 2.86 | 1,063 |
| 14 Aug 2023 | 3.24 | 3.24 | 3.24 | 3.24 | 3.24 | 10,190 |
| 7 Aug 2023 | 2.85 | 2.85 | 2.85 | 2.85 | 2.85 | 867 |
| 24 Jul 2023 | 3.05 | 3.05 | 2.90 | 3.00 | 3.01 | 2,475 |
| 17 Jul 2023 | 3.10 | 3.10 | 3.05 | 3.05 | 3.07 | 2,226 |
| 10 Jul 2023 | 3.30 | 3.30 | 3.20 | 3.20 | 3.28 | 6 |
| 3 Jul 2023 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 23 |
| 26 Jun 2023 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 80 |
| 19 Jun 2023 | 3.69 | 4.00 | 3.69 | 3.96 | 3.91 | 3,029 |
| 12 Jun 2023 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2,250 |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus share history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 26 Jun 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 19 Jun 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 16 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 12 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 10 Jan 2023 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 9 Jun 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 6 Jun 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 21 Feb 2022 | Price move | – | A corporate action went ex within three days of this move (E.G.M., ex-date 23 Feb 2022), and its terms do not account for the move. Not adjusted for. |
| 14 Feb 2022 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 26 Oct 2021 | Price move | – | Between two trading sessions the price moved by a fifth or more. No corporate action is on record. Not adjusted for. |
| 13 Sep 2010 | Bonus | 0.7500 | Holders received 1 bonus share for every 3 held. |
| 2 Nov 2007 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout. Any other event is noted and not adjusted for.
Company details
- Legal name
- Parenteral Drug (India) Ltd.
- BSE code
- 524689
- ISIN
- INE904D01019
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Nov 1994
- Face value
- ₹10
- Former symbols
- PDPL
- CIN
- L24100MH1983PLC126481
- Corporate identity number, the registrar of companies' code for it